Fidelity Investments’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460M | Buy |
16,185,791
+570,727
| +4% | +$16.2M | 0.03% | 513 |
|
|
2025
Q1 | $461M | Sell |
15,615,064
-894,542
| -5% | -$26.4M | 0.03% | 487 |
|
|
2024
Q4 | $480M | Sell |
16,509,606
-339,170
| -2% | -$9.86M | 0.03% | 482 |
|
|
2024
Q3 | $774M | Buy |
16,848,776
+689,729
| +4% | +$31.7M | 0.05% | 342 |
|
|
2024
Q2 | $660M | Buy |
16,159,047
+1,917,411
| +13% | +$78.3M | 0.04% | 352 |
|
|
2024
Q1 | $363M | Buy |
14,241,636
+3,837,540
| +37% | +$97.9M | 0.02% | 559 |
|
|
2023
Q4 | $94.2M | Sell |
10,404,096
-710,335
| -6% | -$6.43M | 0.01% | 1038 |
|
|
2023
Q3 | $70.9M | Buy |
11,114,431
+491,567
| +5% | +$3.14M | 0.01% | 1116 |
|
|
2023
Q2 | $118M | Buy |
10,622,864
+5,203,807
| +96% | +$57.7M | 0.01% | 918 |
|
|
2023
Q1 | $83.2M | Buy |
5,419,057
+493,679
| +10% | +$7.58M | 0.01% | 1049 |
|
|
2022
Q4 | $109M | Buy |
4,925,378
+1,453,059
| +42% | +$32.2M | 0.01% | 937 |
|
|
2022
Q3 | $56.7M | Sell |
3,472,319
-336,804
| -9% | -$5.5M | 0.01% | 1200 |
|
|
2022
Q2 | $55.3M | Sell |
3,809,123
-1,792
| -0% | -$26K | 0.01% | 1214 |
|
|
2022
Q1 | $70.4M | Buy |
3,810,915
+34,391
| +0.9% | +$635K | 0.01% | 1247 |
|
|
2021
Q4 | $89.8M | Sell |
3,776,524
-57,143
| -1% | -$1.36M | 0.01% | 1150 |
|
|
2021
Q3 | $94.4M | Buy |
3,833,667
+439,352
| +13% | +$10.8M | 0.01% | 1129 |
|
|
2021
Q2 | $83.9M | Sell |
3,394,315
-39,273
| -1% | -$970K | 0.01% | 1199 |
|
|
2021
Q1 | $74.9M | Buy |
3,433,588
+9,453
| +0.3% | +$206K | 0.01% | 1207 |
|
|
2020
Q4 | $87.4M | Buy |
3,424,135
+405,304
| +13% | +$10.3M | 0.01% | 1092 |
|
|
2020
Q3 | $85M | Buy |
3,018,831
+185,979
| +7% | +$5.24M | 0.01% | 988 |
|
|
2020
Q2 | $80.1M | Buy |
+2,832,852
| New | +$80.1M | 0.01% | 974 |
|